The global Antisense and RNAi Therapeutics Market Share is poised for significant growth, with the market size projected to expand from USD 4.15 billion in 2023 to USD 18.48 billion by 2032. This growth represents a robust Compound Annual Growth Rate (CAGR) of 18.05% over the forecast period from 2024 to 2032.
Antisense and RNA interference (RNAi) therapeutics are innovative treatments that...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian